The event is over

ESS/MAX IV Summit 2024

How can ESS and MAX IV strengthen the Swedish life science and medtech sectors? That question is in focus at this year's ESS/MAX IV Summit in Mölndal.

Date

17 October 2024

Time

9.00–16.00

Place

Mölnlycke Health Care HQ i Mölndal, Entreprenörsstråket 21. The event will be live-streamed on our YouTube channel External link.

Organisers

The Swedish Research Council, Sweden's innovation agency (Vinnova), ESS, Max IV

Registration

If you want an invitation to participate in Mölndal, please e-mail emk@vr.se.

Facilities like MAX IV and ESS have been used for many years to study drug candidates for, for example, type 2 diabetes and immunotherapies for cancer treatment. Other examples of research conducted at these research infrastructures include improving the thermal stability of biopharmaceutical products or packaging mRNA in nanoparticles for vaccines.

Are the tools and techniques offered at ESS and MAX IV relevant to researchers? How can the facilities incorporate new technologies and tools such as Deep-tech, AI, bioprinting, and nanotechnology to become even better? Who should remove the bottlenecks that hinder the usability of large-scale research infrastructure?

These are some of the questions we will try to answer at this year’s ESS/MAX IV Summit.

The moderator of the event is Maria Borelius.

Programme

Registration opens 8.00.

9.00 Welcome!

  • Darja Isaksson, Director General, Vinnova
  • Katarina Bjelke, Director General, Swedish Research Council

9.15 Mölnlycke Health Care AB & GoCo Health Innovation City

  • Zlatko Rihter, CEO, Mölnlycke Healt Care AB
  • Jacob Torell, VD Steptura

9.25 The conditions for Life Science research in Sweden

Maria Nilsson, State Secretary, Ministry for Education (video

9.30 The future Life Sciences and MedTech in Sweden

Are the tools and techniques offered by ESS and MAX IV relevant to the researchers? What more could MAX IV and ESS do to meet the needs?

  • Zlatko Rihter, CEO, Mölnlycke Health Care AB
  • Fredrik Wessberg, CEO CCRM Nordic
  • Hanna Barriga, Research specialist, SciLifeLab
  • Jan Ellenberg, Director, SciLifeLab

10.15 MAX IV at a glance

  • Olof Karis, Director, MAX IV

10.30 Coffee break

11.15 Big science – a tool for making Sweden even better?

Deep-tech, AI, bioprinting, Nano technology, internet of medical things. The developers of drugs, therapies and personalized medicine, and medtech are using all the new techniques and tools. How does big research infrastructures like ESS and MAX IV fit in? How to incorporate new techniques and tools to be even more successful?

  • Erik Lindahl, Professor of Biophysics, Stockholm University
  • Marianna Yanez Arteta, Associate Director at the Advanced Drug Delivery division within Pharmaceutical Sciences in AstraZeneca
  • Federica Sebastiani, Tenure Track Assistant Professor, Copenhagen University
  • Chris Schlenk, Group Vice President, Wellspect Healthcare

12.00 ESS at a glance

  • Helmut Schober, Director General, ESS

12.15 Lunch is served at GoCo House

13.00 Workshop at Mölnlycke HQ

During lunch the participants will discuss these questions:

  • How do you envision your future use of ESS or MAX IV, i.e. what should the facilities provide to be relevant for you?
  • What do you lack to be able to conduct research or R&D at a large-scale research facility?

13.45 Workshop summary and discussion

14.15 Education, labs, data analysis – who provides what?

Several bottlenecks are slowing down the utility of large-scale research infrastructures, which is bad for science and poor return on investment. Alas, those bottlenecks need to be removed. In this panel we will discuss what needs to change and who should make the change.

  • Pia Kinhult, Head of Host States Relations, ESS
  • Oliver Billker, Director, The laboratory for Molecular Infection Medicine Sweden
  • Selma Maric, Director, ARI4Sweden
  • Jon Sporring, Co-lead, QIM Center

15.00 The conditions for Life Science research in Sweden

How does the Swedish government think, which countries are good role models and why, what does the review of the life science strategy and the upcoming research and innovation bill entail?

  • Maria Nilsson, State secretary, Ministry for Education (tbc)

15.00 Summary

  • Darja Isaksson, Director General, Vinnova
  • Katarina Bjelke, Director General, Swedish Research Council

15.30–17.00 Mingle opportunity

After we finish the Summit, you can mingle with old and new acquaintances at Vigor & Joy inside the GoCo House

PUBLISHED ON

UPDATED ON

Pdf / Printout

Contact

Office for ESS/MAX IV

emk@vr.se

MORE WITHIN THE SAME SUBJECT AREA

  1. EOSC EU node: Information and demonstration

    The first node of the emerging EOSC federation was launched in fall 2024. The node will supply research data and other resources. This webinar is about the EOSC EU node and how you may use it.

  2. How the 2024 funding year turned out

    This year, the Swedish Research Council received around 5 800 applications for research grants. 860 of these were awarded funding. In total, 4.55 billion SEK has been awarded to research at Swedish higher education institutions, and 2.81 billion SEK ...

  3. The Swedish Research Council awarded EU funding for Polar Connect Step 1

    The next sub-project in Polar Connect is now starting – where five Nordic actors join together to secure the global digital infrastructure of the future. The project also entails opportunities to collect data for research into the Arctic.